blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3608312

EP3608312 - SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  24.05.2024
Database last updated on 28.06.2024
FormerGrant of patent is intended
Status updated on  04.02.2024
FormerExamination is in progress
Status updated on  10.01.2024
FormerGrant of patent is intended
Status updated on  01.01.2024
FormerExamination is in progress
Status updated on  29.10.2021
FormerRequest for examination was made
Status updated on  10.01.2020
FormerThe international publication has been made
Status updated on  13.10.2018
Most recent event   Tooltip24.05.2024(Expected) grantpublished on 26.06.2024  [2024/26]
Applicant(s)For all designated states
Xiamen Vivohealths Technology Co., Ltd.
Room 602, Building B13
Xiamen Bio-medicine Industrial Park
2074 West Wengjiao Road
Haicang District
Xiamen, Fujian 361027 / CN
[2020/07]
Inventor(s)01 / DENG, Xianming
4221-120 Xiang'an South Road
Xiang'an District
Xiamen Fujian 361102 / CN
02 / LIN, Shengcai
4221-120 Xiang'an South Road
Xiang'an District
Xiamen Fujian 361102 / CN
03 / ZHANG, Chensong
4221-120 Xiang'an South Road
Xiang'an District
Xiamen Fujian 361102 / CN
 [2020/07]
Representative(s)Colombo, Stefano Paolo, et al
Marchi & Partners S.r.l.
Via Vittor Pisani, 13
20124 Milano / IT
[2020/07]
Application number, filing date18781729.104.04.2018
[2020/07]
WO2018CN81898
Priority number, dateCN20171022312507.04.2017         Original published format: CN201710223125
[2020/07]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018184561
Date:11.10.2018
Language:ZH
[2018/41]
Type: A1 Application with search report 
No.:EP3608312
Date:12.02.2020
Language:EN
[2020/07]
Type: B1 Patent specification 
No.:EP3608312
Date:26.06.2024
Language:EN
[2024/26]
Search report(s)International search report - published on:CN11.10.2018
(Supplementary) European search report - dispatched on:EP29.09.2020
ClassificationIPC:C07D235/08, C07D233/02, A61K31/4184, A61K31/4174, A61P3/06, A61P25/28, A61P35/00, A61P1/16
[2020/07]
CPC:
A61P1/16 (EP); C07D233/60 (EP,CN,US); A61P25/16 (EP);
A61P25/28 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P39/06 (EP);
C07D233/56 (CN); C07D233/58 (EP,CN); C07D233/61 (CN,US);
C07D235/08 (EP); C07D235/10 (CN,US); C07D235/12 (CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/07]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:SUBSTITUIERTE IMIDAZOLSALZVERBINDUNGEN, HERSTELLUNGSVERFAHREN DAFÜR, PHARMAZEUTISCHE ZUSAMMENSETZUNG DAVON UND ANWENDUNGEN DAVON[2020/07]
English:SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF[2020/07]
French:COMPOSÉS DE SEL D'IMIDAZOLE SUBSTITUÉS, LEUR PROCÉDÉ DE PRÉPARATION, COMPOSITION PHARMACEUTIQUE ET APPLICATIONS ASSOCIÉES[2020/07]
Entry into regional phase04.11.2019Translation filed 
04.11.2019National basic fee paid 
04.11.2019Search fee paid 
04.11.2019Designation fee(s) paid 
04.11.2019Examination fee paid 
Examination procedure04.11.2019Examination requested  [2020/07]
26.04.2021Amendment by applicant (claims and/or description)
03.11.2021Despatch of a communication from the examining division (Time limit: M06)
02.05.2022Reply to a communication from the examining division
09.08.2022Despatch of a communication from the examining division (Time limit: M04)
12.12.2022Reply to a communication from the examining division
28.03.2023Despatch of a communication from the examining division (Time limit: M04)
21.07.2023Reply to a communication from the examining division
02.01.2024Communication of intention to grant the patent
09.01.2024Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
05.02.2024Communication of intention to grant the patent
20.05.2024Fee for grant paid
20.05.2024Fee for publishing/printing paid
20.05.2024Receipt of the translation of the claim(s)
Fees paidRenewal fee
04.11.2019Renewal fee patent year 03
30.04.2021Renewal fee patent year 04
27.04.2022Renewal fee patent year 05
29.03.2023Renewal fee patent year 06
29.04.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]BE696982  ;
 [A]WO2008006432  (MERCK PATENT GMBH [DE], et al);
 [X]WO2014199352  (INVICTUS ONCOLOGY PVT LTD [IN]);
International search[A]WO2009123569  (AGENCY SCIENCE TECH & RES [SG], et al);
 [A]WO2009133923  (ISHIHARA SANGYO KAISHA [JP], et al);
 [A]CN101983057  (AGENCY SCIENCE TECH & RES);
 [A]CN103547154  (UNIV AKRON)
ExaminationDE2706839
 JP2009215200
 CN101698660
 US8592585
 WO2018106922
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.